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Background: Although the oxidative stress status in atopic skin disease has been reported to be elevated, there are still
no studies related to the status of oxidative stress in atopic ocular surface disease. The purpose of this study was to evaluate
the ocular surface lipid oxidative stress status and inflammation in atopic keratoconjunctivitis (AKC) patients and normal
subjects.
Methods: Twenty eight eyes of 14 patients (9 males, 5 females) with AKC and 18 eyes of 9 age and sex matched (4 males
and 5 females) normal healthy controls were examined in this prospective study. The severity of atopic dermatitis (AD)
was scored by the SCORing Atopic Dermatitis (SCORAD) index. All subjects underwent Schirmer test, tear film break
up  time  (BUT),  fluorescein/Rose  Bengal  stainings,  tear  collection,  and  brush  cytology  from  the  upper  palpebral
conjunctiva. The brush cytology samples were stained with Diff-Quik for differentiation of inflammatory cells and
immunohistochemistry (IHC) staining with HEL (hexanoyl-lysine) and 4-HNE (4-hydroxy-2-nonenal) to study lipid
oxidation. HEL and cytokine (interleukin-4 (IL-4), interleukin-5 (IL-5), interleukin-10 (IL-10), tumor necrosis factor-
alpha (TNF-α), interferon-gamma (IFN-γ)) levels were measured by enzyme-linked immunosorbent assay (ELISA) from
tear samples of AKC patients and control subjects. Toluidine Blue and IHC staining with HEL, 4-HNE and cluster of
differentiation 45 (CD45) were performed on papillary samples of AKC patients. This study was conducted in compliance
with the “Declaration of Helsinki.”
Results: The tear stability and vital staining scores were significantly worse in eyes of AKC patients (p<0.05) compared
to the controls. Inflammatory cells and positively stained conjunctival epithelial cells for HEL and 4-HNE showed a
significant elevation in brush cytology samples of AKC patients. Significantly higher levels of HEL and cytokines were
detected in tears of AKC patients compared to controls. Papillary specimens also revealed many CD45 inflammatory cells
as well as many cells positively stained with HEL and 4-HNE in IHC. A strong significant linear positive correlation
between conjunctival inflammation and epithelial lipid oxidative stress status was observed. Conjunctival lipid oxidative
stress also correlated strongly with tear HEL levels and epithelial damage scores.
Conclusions: The ocular surface disease in AKC was characterized by marked tear instability, ocular surface epithelial
damage, increase in inflammatory infiltrates and presence of increased lipid oxidation.
Atopic  dermatitis  (AD)  is  a  worldwide  public  health
problem  with  an  increase  in  prevalence  and  morbidity  in
recent decades [1,2].
Atopic Keratoconjunctivitis (AKC) is a bilateral, chronic
inflammation of the conjunctiva and lids associated with AD.
The primary symptoms and signs of AKC include itching of
the lid skin, periorbital area, conjunctiva, tearing, mucous
discharge,  burning,  photophobia  and  blurred  vision.  The
conjunctival involvement may vary from a normal looking
conjunctiva  to  severe  papillary  hypertrophy,  subepithelial
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fibrosis,  and  symblepharon  formation.  However,  it  is  the
corneal  problems  that  are  the  vision-limiting  factors  [3].
Although  the  mechanisms  involved  in  the  allergic
inflammation of AKC are not completed clear, T-cell driven
inflammatory  processes,  infiltrations  with  mast  cells,
eosinophils and other inflammatory cells seem to play a major
role. A better understanding of the mechanisms that underline
the AKC is therefore critical for the design of a new and more
effective treatment protocols for this disease.
Skin inflammation in AD is histologically characterized
by  intense  infiltration  of  lymphocytes,  monocytes  and
eosinophils  which  have  been  reported  to  release
proinflammatory  cytokines  and  reactive  oxygen  species
(ROS) such as O2
-, H2O2 and peroxinitrite (ONOO-), upon
immunological and non-immunological stimulation [4-7].
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2465Although the oxidative stress status in atopic skin disease
has been reported to be elevated [8,9], there are still no studies
related to the status of oxidative stress in atopic ocular surface
disease.  We  investigated  whether  oxidative  stress  related
changes were present in the ocular surface of patients with
AKC comparing the results with healthy control subjects.
METHODS
Subjects: Twenty-eight eyes of 14 AKC patients with AD (9
males, 5 females) aged between 11 and 43 years (mean: 22.6
years) as well as 18 eyes of 9 normal subjects aged from 20
to 35 years (mean: 25.2 years; 4 males and 5 females) were
recruited from the Ocular Allergy Subspecialty Clinic of the
Department of Ophthalmology, Mita Hospital, International
University of Health and Welfare in this prospective study.
All AKC patients had active ocular disease in this study.
The  severity  of  AD  was  assessed  by  the  Scoring  Atopic
Dermatitis  (SCORAD)  index  [10,11].  Venous  peripheral
blood was collected and enzyme-linked immunosorbent assay
(ELISA) test to detect the specific immunoglobulin E (IgE)
antibodies to 26 allergens was performed using the MAST 26
Allergen Kit in all subjects (SRL, Tokyo, Japan). None of the
patients  had  a  history  of  Stevens-Johnson  syndrome,
chemical, thermal, radiation injury, bacterial, viral or toxic
conjunctivitis; or underwent any ocular surgery that would
create an ocular surface problem. As ethic board committee
did not allow a washout period in subjects with an active
disease to study the naïve ocular surface status, only patients
who  were  recalcitrant  to  the  same  treatment  regimen
prescribed at their referral centers were recruited. No patient
was  being  treated  with  systemic  cytotoxic
immunosuppressants,  steroids,  or  prostaglandin  inhibitors.
Control subjects did not have any history of ocular or systemic
disease and any history of drug or contact lens use that would
alter the ocular surface as well. An informed consent about
the  procedures  as  well  as  permission  from  the  Ethical
Committee  of  Mita  Hospital,  International  University  of
Health and Welfare was obtained. This study adhered to the
tenets of the Declaration of Helsinki.
Tear function tests and ocular surface vital staining scores:
At slit-lamp examination, particular attention was paid to lid
margins,  tarsal  and  bulbar  conjunctiva  and  cornea.
Conjunctival injection grade was classified with a scale of
severity score ranging from zero (no conjunctival injection)
to 3 (severe conjunctival injection).
The standard tear film break up time (BUT) measurement
was  performed.  Two  microlitres  of  preservative-free
combination  of  1%  fluorescein  dye  was  instilled  in  the
conjunctival sac. The dye was introduced to the conjunctival
sac with a micropipette. The subjects were then instructed to
blink several times for a few seconds to ensure adequate
mixing of the dye. The interval between the last complete
blink and the appearance of the first corneal black spot in the
stained tear film was measured three times and the mean value
of  the  measurements  was  calculated.  A  BUT<10  s  was
considered abnormal [12]. Fluorescein staining of the cornea
was also noted and scored. Fluorescein staining scores ranged
between zero and nine points [13]. A score >3 points was
regarded as abnormal [14]. For further evaluation of tears, the
standard  Schirmer  test  with  topical  anesthesia  (0.4%
oxybuprocaine chloride) was performed. The standardized
strips of filter paper (Showa Yakuhin Kako Co., ltd, Tokyo,
Japan) were placed in the lateral canthus away from the cornea
and left in place for 5 min with the eyes closed. Readings were
reported in millimeters of wetting for 5 min. A reading of
<5 mm was referred to as dry eye [15].
Tear collection: Using a capillary micropipette, tears were
gently collected from the external canthus, taking precaution
to avoid reflex tearing. Tear samples were collected before the
vital staining examination. Following collection, tears were
placed in Eppendorff tubes and centrifuged at 13,600× g for
5 min at 4 °C. The supernatants were then stored at −80 °C
until assayed.
Conjunctival brush cytology: The brush cytology specimens
were obtained after administration of topical anesthesia with
0.4% oxybuprocaine. Two adjacent nonoverlapping areas of
central upper palpebral conjunctiva were used for sampling.
Conjunctiva was scraped seven times with the Cytobrush-S
(Medscand AB, Malmö, Sweden), the examiner holding the
brush  2  cm  away  from  the  brush  end,  applying  a  gentle
pressure to the conjunctiva. After sampling, the brushes were
immediately placed in 1 ml of Hank’s buffered solution, and
the containers were shaken to detach the cells from the brush.
The suspended cells were collected using the Millipore filter
technique employing filters with 8 μm pore size. One slide
was allocated for the assessment of conjunctival inflammatory
cells number by Diff Quik staining.
Surgical  technique  for  papillae  resection  and
histopathological  assessment  of  specimens:  After  topical
anesthesia  with  4%  lidocaine  eye  drops,  0.2  ml  of  2%
lidocaine was injected to the upper fornix. The cobblestone-
like  papillae  including  subconjunctival  connective  tissues
were  removed  using  sharp  dissection.  Then,  0.1%
methylprednisolone ointment was applied to the conjunctival
sac, and a pressure eye patch was maintained for 1 day. Tissue
samples  were  fixed  overnight  in  formalin  solution  and
processed for paraffin embedding. Sections (5 µm) were cut
from paraffin wax blocks and mounted on pre-coated glass
slides. Inflammatory cells were detected by toluidine blue
staining  and  immunohistochemistry  with  anti-cluster  of
differentiation  45  (anti-CD45)  primary  antibody.  Lipid
oxidative  stress  status  was  visualized  by
immunohistochemistry with anti-HEL (anti- hexanoyl-lysine)
and  anti-4-HNE  (anti-4-hydroxy-2-nonenal)  primary
antibodies.
Immunohistochemical  staining:  Oxidative  stress  induced
lipid  peroxidation  was  assessed  by  immunohistochemical
Molecular Vision 2010; 16:2465-2475 <http://www.molvis.org/molvis/v16/a264> © 2010 Molecular Vision
2466detection  of  HEL  (hexanoyl-lysine;  early  phase  oxidative
stress marker) and 4-HNE (4-hydroxy-2-nonenal; late phase
oxidative stress marker) protein adducts. The avidin–biotin–
peroxidase  complex  (ABC)  method  was  used  for
immunostaining.  Brush  cytology  samples  were  fixed  in
paraformaldehyde 4% before the staining procedure. Tissue
samples  were  fixed  overnight  in  formalin  solution  and
processed for paraffin embedding. Sections (5 µm) were cut
from paraffin wax blocks, mounted on pre-coated glass slides,
deparaffinized,  and  rehydrated.  Antigen  retrieval  was
achieved by microwaving in 10 mmol/l sodium citrate buffer
for 5 min then cooling for 20 min. To block nonspecific
background staining, sections were treated with normal horse
serum (Vector Laboratories, Burlingame, CA) for 1 h at room
temperature. The sections were then incubated for 90 min with
the following monoclonal mouse primary antibodies: anti-4-
HNE at a dilution of 1:4 (JaICA, Shizuoka, Japan), anti-HEL
at a dilution of 1:10 (JaICA) and anti-CD45 at a dilution of
1:50 (BioLegend, San Diego, CA). For the negative controls,
the  primary  antibody  was  replaced  with  mouse
immunoglubulin G1 kappa (IgG1κ) (Sigma, St. Louis, MO).
Endogenous  peroxidase  activity  was  blocked  using  3.0%
TABLE 1. COMPARISON OF TEAR FUNCTIONS AND OCULAR SURFACE VITAL STAININGS BETWEEN AKC PATIENTS AND HEALTHY CONTROL SUBJECTS.
Tear functions and ocular surface vital staining scores AKC patients Control subjects
Tear break-up time (BUT - seconds) 5.1±2.6* 7.8±2.3
Schirmer test 1 (mm) 11.7±8.7* 18.1±8.1
Fluorescein staining (0-9 points) 3.9±3.2* 0.4±1.0
Conjunctival injection grade (0-3points) 2.0±1.0* 0.1±0.2
The asterisk indicates a p< 0.05 using the Mann-Whitney Test.
Figure 1. Representative anterior segment photographs and brush cytology samples showing comparison of inflammatory cell infiltrates in
an AKC patient and a control. Anterior segment photographs show extensive corneal damage visualized by the fluorescein staining in patient
with AKC. Note that the superficial punctate keratopathy is present in almost all the surface of the cornea and is associated to the increased
proliferation of the conjunctival papillae (A, B). The photograph on the left side represents a normal cornea with no conjunctival proliferation
on the tarsal conjunctiva (C, D). Note the extensive inflammatory infiltrates in Diff-Quik staining from brush cytology samples in the AKC
patient (E) compared with the healthy control subject (G). The graphic shows the comparison of mean percentage inflammatory cells stained
by DQ between the two groups (F).
Molecular Vision 2010; 16:2465-2475 <http://www.molvis.org/molvis/v16/a264> © 2010 Molecular Vision
2467H2O2 in methanol for 3 min. The sections were incubated for
30  min  with  biotin-labeled  horse  anti-mouse  IgG  serum
(Vector Laboratories, Burlingame, CA), followed by avidin-
biotin-alkaline phosphatase complex (Vector Laboratories)
for  30  min.  The  sections  were  washed  in  PBS  buffer,
developed  in  prepared  3,3′-diaminobenzidine  (DAB)
chromogen solution, lightly counterstained with hematoxylin,
dehydrated, and mounted.
Quantification of oxidative damage and eosinophil staining:
All brush cytology specimens from each patient and control
subjects  were  evaluated  using  light  microscopy  at  40×
magnification  for  the  presence  of  positive
immunohistochemical staining for oxidative stress markers
(HEL and 4-HNE) and eosinophils. The number of positively
HEL and 4-HNE stained cells was counted within a total of
one hundred conjunctival epithelial cells, in a masked fashion.
The number of eosinophils was counted within a total of one
hundred  inflammatory  cells.  The  counting  technique  was
repeated 5 times in nonoverlapping random areas for each
specimen  and  cell  density  results  were  expressed  in
percentage of stained cells.
Enzyme-linked immunosorbent assay (ELISA) for tear HEL
and Cytokine assessment:
Measurement  of  tear  HEL  levels—A  commercially
available  HEL  enzyme-linked  absorbant  assay  (ELISA;
JaICA) was used to determine the tear HEL concentration, as
reported previously [16]. We also investigated the correlation
between  tear  HEL  levels  and  numbers  of  cells  positively
stained with HEL in conjunctival brush cytology specimens.
Measurement of tear cytokine levels—Tear samples
were taken from each eye with 10 µl glass capillary tubes in
the same manner as described above. Following collection,
the tears were centrifuged at 13,600× g for 5 min at 4 °C. The
supernatants were removed and stored at −80 °C. The BD
Cytometric Bead Array Human Th1/Th2 Cytokine Kit (BD
Biosciences, San Jose, CA) was used in combination with the
BD  FACSCalibur™  flow  cytometer  (BD  Biosciences)  to
qualitatively  measure  interleukin-4  (IL-4),  interleukin-5
(IL-5), interleukin-10 (IL-10), tumor necrosis factor-α (TNF-
α), and interferon-γ (IFN-γ) according to the manufacturer’s
instructions, as previously reported [17,18]. The data acquired
from the flow cytometer was processed using the BD™ CBA
Analysis Software (BD Biosciences).
Statistical  analysis:  Data  were  processed  using  Instat,
GraphPad software version of InStat 3.0 (San Diego, CA). The
Mann–Whitney  test  was  used  to  compare  the  parameters
Figure 2. Representative immunohistochemistry stainings for the early lipid oxidation marker in brush cytology specimens from an AKC
patient and a control subject. Note the extensive lipid oxidative stress damage in the HEL immunohistochemistry staining from brush cytology
samples of an AKC patient (A) compared to the healthy control subject (D). Note the significantly higher percentage of cells stained by HEL
in patients with AKC (C). B and E represent the negative controls from the immunohistochemistry.
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2468between  the  AKC  subjects  and  the  normal  controls.  The
correlation  between  tear  HEL  levels  and  number  of  cells
positively  stained  with  lipid  oxidative  stress  markers  in
conjunctival  brush  cytology  specimens  as  well  as  the
correlation between corneal damage scores and number of
cells positively stained with lipid oxidative stress markers and
inflammatory  cells  were  studied  by  using  the  Spearman
correlation analysis. A probability level of less than 5% was
considered statistically significant.
RESULTS
Patient characteristics: Patients with AKC had active mild to
severe AD with positive personal or family history of atopic
disease. The mean SCORAD index score was 38.94±18.48.
The most frequent sensitizing allergens in patients with AKC
were Dermatophagoides pteronyssinus, cedar tree pollen, and
Phleum  pratense  pollen.  All  patients  had  active  AKC  as
evidenced  by  conjunctival  injection,  chemosis,  papillary
hypertrophy, tearing, and mucus discharge. There were no
age- or gender-related differences between the patients and
the control subjects. All patients complained of allergic and
dry  eye  symptomatology,  including  itchiness,  redness,
grittiness,  tiredness,  discomfort  and  irritation.  The  mean
conjunctival  injection  grade  for  AKC  patients  was
significantly  (2.0±1.0)  greater  than  the  normal  control
subjects (0.1±0.2; p<0.0001).
Tear function tests and ocular surface findings: The mean
BUT score in eyes with AKC was significantly lower than in
eyes of healthy control subjects as shown in Table 1 (p<0.05).
The mean BUT values were 5.1±2.6 s and 7.8±2.3 s in AKC
patients  and  control  subjects,  respectively.  The  mean
Schirmer test scores were normal in both patient and control
groups with a significantly lower value in eyes with AKC
compared with eyes of control subjects (p<0.05), (Table 1).
The mean fluorescein scores were 3.9±3.2 points and 0.4±1.0
points in AKC patients and control subjects, respectively. The
differences were statistically significant (p<0.0001).
Staining and quantification for eosinophils in brush cytology
samples:  Brush  cytology  reveled  significantly  higher
percentage  of  eosinophils  in  eyes  with  AKC  (4.5±5.12)
compared with healthy control eyes (0.05±0.11) as shown in
Figure  1.  (p<0.0001).  The  number  of  eosinophilic  cells
showed  a  significant  positive  correlation  with  corneal
fluorescein  staining  scores  (data  not  shown;  r=0.62,
p<0.0001).
Figure 3. Representative immunohistochemistry stainings for the late lipid oxidation marker in brush cytology specimens from an AKC patient
and a control subject. Note the extensive lipid oxidative stress damage in the 4HNE immunohistochemistry staining from brush cytology
samples of an AKC (A) patient compared to the healthy control subject (D). Note the significantly higher percentage of cells stained by 4HNE
in patients with AKC (C). B and E represent the negative control from the immunohistochemistry.
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2469Immunohistochemistry stainings for HEL and 4-HNE and
quantification  of  lipid  oxidative  stress  damage:  All
conjunctival specimens from AKC patients revealed marked
staining for HEL and 4-HNE, in the epithelial cells from brush
cytology specimens compared to control subjects as shown in
Figure 2 and Figure 3. The average percentages of positively
stained epithelial cells for 4-HNE and HEL antibodies in the
AKC  subjects  were  74.71±17.15%  and  58.01±21.61%,
respectively. In the control group, the average percentages of
positively stained conjunctival epithelial cells for 4-HNE and
HEL were 6.85±14.13%, and 8.62±13.3%, respectively. The
differences were statistically significant (p<0.0001).
ELISA for measurement of tear cytokine levels: IL-4, IL-5,
and TNF-α cytokine concentrations were significantly higher
in the eyes of patients with AKC compared with the eyes of
healthy control subjects, as shown in Figure 4 (p<0.05). The
mean  IL-4,  IL-5,  and  TNF-α  tear  cytokine  levels  were:
31.01±37.95 pg/ml, 173.09±333.5 pg/ml and 14.35±11.31 pg/
ml in AKC patients, respectively. The corresponding tear
cytokine levels in control subjects were: 15.88±9.59 pg/ml,
9.36±5.16 pg/ml, 9.05±4.06 pg/ml, respectively. Tear IL-5
and TNF- α cytokine concentration showed a significant linear
positive correlation with conjunctival cell numbers positively
stained  with  HEL.  Tear  IL-5  cytokine  also  showed  a
significant linear positive correlation with conjunctival cell
numbers positively stained with 4-HNE as shown in Table 2.
ELISA for measurement of tear HEL levels: The tear HEL
concentration was significantly higher in the eyes of patients
with AKC (8653.1±2145.7 pg/ml) compared with the eyes of
healthy control subjects (1789.4±2089.8 pg/ml), as shown in
Figure 5 (p<0.0001).
Immunohistochemistry  staining  for  conjunctival  papillae
samples:  Papillary  tissues  from  AKC  patients  presented
marked positive staining for CD45 antibody, oxidative stress
damage markers (HEL and 4-HNE) and increased number of
eosinophils, Figure 6.
Correlation  of  Tear  HEL  concentration  with  conjunctival
HEL  staining:  The  tear  HEL  concentrations  showed  a
significant  linear  positive  correlation  with  percentages  of
positively  stained  cells  for  HEL  in  conjunctival  brush
cytology specimens (r=0.59, p<0.05) as shown in Figure 7A.
Correlation of eosinophil cell density and corneal epithelial
damage with conjunctival HEL staining: The percentages of
positively stained cells for HEL showed a significant linear
positive correlation with corneal fluorescein staining scores
(r=0.65,  p<0.0001)  and  with  the  eosinophil  cell  numbers
(r=0.72, p<0.0001) as shown in Figures 7B,C.
Figure 4. Comparison of tear cytokine
levels between AKC patients and age
and  sex  matched  healthy  control
subjects.
TABLE 2. CORRELATIONS BETWEEN TEAR IL-4, IL-5, AND TNF-Α CYTOKINE LEVELS AND HEL AND 4-HNE POSITIVELY STAINED CELLS.
  Oxidative lipid peroxidation marker staining (%)
  HEL 4-HNE
Protein Spearman correlation coefficient p value Spearman correlation coefficient p value
IL-4 r=0.2070 >0.05 r=0.0820 >0.05
IL-5 r=0.7806 <0.0001* r=0.5646 <0.05*
TNF-α r=0.4148 <0.05* r=0.2751 >0.05
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damage with conjunctival 4HNE staining: The percentages of
positively stained cells for 4-HNE showed a significant linear
positive correlation with corneal fluorescein staining scores
(r=0.64,  p<0.05)  and  with  the  eosinophil  cell  numbers
(r=0.62, p<0.05) as shown in Figures 8A,B.
DISCUSSION
Cells generate energy by reducing oxygen to water during
which reactive oxygen species are generated. The generation
of free radicals has been reported to lead to tissue injury
through induction of inflammation in several disease states
including  sepsis,  ischemic  heart  and  brain  disease,
atherosclerosis, asthma and AD [8,9,19-23].
Increased oxidative stress status, specially elevation of
ROS, has been described in patients with AD. Indeed, urine
concentrations of 8-hydroxy-2’-deoxyguanosine (8-OHdG),
a  marker  for  oxidative  DNA  damage,  and  acrolein-lysine
adducts, a marker of lipid peroxidation, have been reported to
be higher in AD patients compared to controls [8,9]. Oxidative
stress  changes  in  AD  have  been  reported  extensively  in
Dermatology literature. Niwa et al. confirmed the presence of
lipid  peroxidation,  detected  by  4-  HNE,  in  the  stratum
corneum of patients with AD [24]. The skin inflammation in
AD was histologically characterized by intense infiltration of
lymphocytes, monocytes and eosinophils [4,25]; all of which
may  release  bioactive  substances  including  inflammatory
cytokines  and  ROS  upon  immunological  and  non-
immunological stimulation [5]. There is futher evidence in the
literature that circulating polymorphonuclear leucocytes from
AD patients are hyperreactive, showing enhanced release of
reactive  oxygen  intermediates  [26,27],  suggesting  the
possibility that these changes may lead to a vicious cycle
further causing immune activation, oxidative damage, and
propagation of skin inflammation.
In the field of Ophthalmology, oxidative stress damage
has been reported to play a role in several ocular diseases
including age-related macular degeneration [28,29], cataract
[30], uveitis [31], retinopathy of prematurity [32], corneal
inflammation [33,34], keratitis [35], and conjunctivochalasis
[36], an aging disease of the conjunctiva characterized by
conjunctival laxity.
Although the oxidative stress status in atopic skin disease
has been reported to be elevated, there are still no studies
related to the status of oxidative stress in atopic ocular surface
disease.
In this study, we investigated the lipid oxidative stress
related changes in the tear film and brush cytology samples of
patients with AD comparing the results with healthy control
subjects. We also performed a histopathological assessment
of lipid peroxidation staining in papillary resection samples
of patients with severe AKC.
The  tear  stability,  quantity,  ocular  surface  epithelial
damage and conjunctival injection scores were significantly
worse in patients with AKC compared with controls which
were  consistent  with  previously  published  studies.  Brush
cytology  revealed  a  significantly  higher  extent  of
inflammatory  infiltrates,  mainly  of  eosinophils  in  AKC
patients.  Another  piece  of  evidence  for  increased  ocular
surface inflammation was based on significant increases in the
concentration of TNF-α, IL-5, and IL-4 in tears of patients
with AKC compared with controls. Not only the systemic
disease process that favors a Th2 cytokine dominant response
in AD but the environmental conjunctival allergen exposure
Figure 5. Comparison of tear hexanoyl-
lysine levels between AKC patients and
age  and  sex  matched  healthy  control
subjects.
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2471might  have  led  to  the  recruitment  and  activation  of
inflammatory cells in the conjunctiva.
Allergen exposure has been shown to be associated with
release of IL-5 and IL-13 from inflammatory cells in allergic
airway  exposure  and  associated  with  oxidative  stress  in
BALB/c mice [37]. In vitro studies on primary cultures of
purified human CD4+ T cells showed evidence that oxidative
stress  could  be  induced  which  in  turn  modulated  T  cell
polarization toward Th2 cytokine producing cells, including
IL-4, IL-5, and IL-13 [38]. Inflammatory cells are also known
to  release  reactive  oxygen  products.  It  is  our  belief  that
allergens induce recruitment of inflammatory cells including
mast cells, lymphocytes, eosinophils, and neutrophils in AKC,
which  not  only  release  inflammatory  cytokines  but  free
oxygen radicals as well.
Our  efforts  to  investigate  the  lipid  oxidative  stress
changes  interestingly  revealed  higher  percentages  of  cells
positively stained for HEL (early phase lipid peroxidation
marker) and 4-HNE (late phase lipid peroxidation marker) in
palpebral conjunctival samples suggesting an increased lipid
peroxidation status in AKC. The lipid peroxidation marker
HEL was also significantly increased in tears of patients with
AKC compared with controls.
Although  palpebral  conjunctival  tissue  samples  from
healthy control subjects could not be obtained due to lack of
ethic board permission, palpebral conjunctiva covering the
papillary  formations  during  papillary  resection  surgery  in
patients  with  severe  AKC  showed  dense  mast  cells  and
CD45+ inflammatory cells as well as marked stainings for
HEL and 4-HNE antibodies providing further evidence that
conjunctival inflammation and lipid peroxidation coexisted in
AKC.
There  is  increasing  evidence  that  atopic  diseases  are
intimately linked to the generation of oxidative stress. While
the  oxidative  stress  could  be  the  consequence  of  oxygen
radical  production  by  macrophages,  neutrophils,  and
eosinophils, it is important to understand that oxidative stress
could also be an inciting factor in the generation of ocular
surface inflammation. Oxidative free radicals directly oxidize
various  macromolecules  including  lipids.  It  has  been
described in the literature that lipid peroxides and their break-
down products, such as HEL and 4-HNE, can directly or
indirectly affect many functions integral to cellular and organ
homeostasis.  As  a  result,  the  increased  membrane  lipid
peroxidation  may  evoke  and/or  increase  the  immune  and
inflammatory  response,  activate  gene  expression  and  cell
proliferation,  or  initiate  apoptosis  [39].  Thus,  a  close
relationship  between  ROS  production,  peroxidative  lipid
membrane damage and an inflammatory pathological process
may be postulated for the ocular surface disease in AKC.
Our correlation analysis showed a significant positive
correlation between tear HEL levels and conjunctival HEL
Figure 6. Representative immunohistochemistry staining for oxidative stress and inflammatory cell markers in papillae samples from an AKC
patient. Note the presence of several inflammatory cells characterized by eosinophils in dark-pink color stained by toluidine blue (A). The
polymorph inflammatory cells are stained by the anti-CD45 antibody and evidenced by dark-brown staining (B). The presence of oxidative
stress damage is observed by the immunohistochemistry staining for 4HNE (C) and HEL (D). Note that the dark-brown color represents the
oxidative stress damage sites.
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2472staining  whereas  another  strong  positive  correlation  was
observed between eosinophilic inflammatory cell numbers
and the extent of early and late lipid peroxidation as evidenced
by the higher percentages of positively stained cells for HEL
and  4-HNE  in  specimens  harboring  higher  eosinophil
densities.  The  extent  of  early  and  late  lipid  peroxidation
marker stainings also showed a strong positive correlation
with corneal epithelial damage.
Peroxidation of membrane lipids might have very well
induced  perturbation  of  ocular  surface  epithelial  cellular
functions causing breakdown and death of epithelial cells
which  might  have  contributed  to  increased  epithelial
fluorescein staining scores. TNF-α, which is known to induce
inflammation and cell death, was also elevated in tears of AKC
patients.  The  pathways  regulating  the  elevation  of  lipid
oxidation  status  and  linking  it  to  inflammation  are  still
unclear. Whether upregulation of STAT 6 with increased NF-
kB  activity  results  in  Th2  favored  cytokine  response  and
induce  oxidative  stress  in  allergic  ocular  surface  disease
remains to be investigated in future studies.
It  also  remains  the  further  goal  of  future  studies  to
determine  short  and  long-term  conjunctival  epithelial
cytology staining status with oxidative stress markers and
their correlation to inflammatory cytokine markers that may
open up some new avenues of categorizing, diagnosing, and
treating different cryptic elements of AKC and AD. Further
studies investigating the simultaneous alterations of the ocular
surface  anti-oxidant  status  will  also  provide  invaluable
information.
It is also our wish that the observations from the current
study will pave the way to newer studies testing the efficacy
of  anti-oxidant  treatment  strategies  in  AKC.  Indeed,
Figure  7.  Correlation  between
inflammation,  corneal  epithelial  cell
damage  and  HEL  tear  levels.
Conjunctival lipid oxidative stress was
strongly correlated with tear HEL levels
(A) and conjunctival inflammation (B).
A significant linear positive correlation
between epithelial damage scores and
epithelial  lipid  oxidative  stress  status
was observed (C).
Figure  8.  Correlation  between
inflammation,  corneal  epithelial  cell
damage  and  4-HNE  staining.
Conjunctival lipid oxidative stress (4-
HNE) was correlated with conjunctival
inflammation (A) and corneal epithelial
damage scores (B).
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2473antioxidant defense impairment in atopic dermatitis has been
confirmed in a study reporting that N-acetyl cystein (NAC)
was able to down-regulate Th2-secreted-cytokines, such as
IL-4,  IL-5  with  a  subsequent  over-activation  of  the  Th1
response, suggesting that in Th2 related diseases, such as
atopic dermatitis, NAC might serve as a possible therapeutic
agent  [40].  Recent  studies  also  suggest  squalene
monohydroperoxide  is  a  primary  oxidized  lipid  generator
which is elevated in atopic dermatitis. Antioxidants, such as
catechin, or ascorbic acid which have been shown to markedly
decrease  the  cytotoxicity  of  squalene  monohydroperoxide
may find roles in the treatment of AKC in the future [41].
In summary, this study provided the first evidence that
lipid  peroxidation  and  inflammation  coexisted  in  the
conjunctiva of patients with AKC, a finding which might hold
the keys to future explanations for the pathogenesis of the
ocular surface disease in AKC.
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